Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial(†)

AIMS: In the Digitalis Investigation Group (DIG) trial, digoxin reduced mortality or hospitalization due to heart failure (HF) in several pre-specified high-risk subgroups of HF patients, but data on protocol-specified 2-year outcomes were not presented. In the current study, we examined the effect...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Gheorghiade, Mihai, Patel, Kanan, Filippatos, Gerasimos, Anker, Stefan D., van Veldhuisen, Dirk J., Cleland, John G.F., Metra, Marco, Aban, Inmaculada B., Greene, Stephen J., Adams, Kirkwood F., McMurray, John J.V., Ahmed, Ali
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2013
Gaiak:
Treatment
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3707428/
https://ncbi.nlm.nih.gov/pubmed/23355060
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurjhf/hft010
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak